Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BYInsights into imaging

Myocardial work in light-chain and transthyretin-related amyloidosis with preserved ejection fraction: a cardiovascular magnetic resonance study

Abstract

Objectives: To investigate pressure–volume loop (PV-loop) changes by cardiovascular magnetic resonance (CMR) imaging in cardiac amyloidosis (CA) patients with preserved left ventricular ejection fraction (LVEF), and to assess PV-loop parameters’ potential as subtype differential diagnostic markers.

Materials and methods: Between May 2017 and September 2023, 100 consecutive confirmed CA patients (14 transthyretin-related [ATTR-CA] and 86 light-chain [AL-CA]) and 40 age- and sex-matched healthy controls (HCs) were prospectively enrolled. PV-loop parameters were derived from CMR cine images and brachial blood pressure. Clinical and CMR parameters were compared between CA patients and HCs, as well as between CA subtypes. The correlations between PV-loop parameters and clinical and imaging parameters were assessed. Furthermore, the differential diagnostic performance of these PV-loop parameters was evaluated using the area under the receiver operating characteristic curve (ROC-AUC). Bootstrapping was performed 2000 times for internal validation.

Results: Compared to HCs, CA patients showed significantly lower stroke work index, potential energy index (PEI), and work efficiency (all p < 0.001). AL-CA patients had higher N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (2358.00 [IQR: 903.25, 5559.00] vs 810.00 [IQR: 269.00, 1136.01] pg/mL, p = 0.002) and lower PEI (0.13 [IQR: 0.07, 0.15] vs 0.15 [IQR: 0.13, 0.19] J/m², p = 0.025) than ATTR-CA patients. NT-proBNP (β = −1.94, OR = 0.14, 95% CI: 0.03–0.64, p = 0.016) and PEI (β = 0.20, OR = 1.23, 95% CI: 1.07–1.44, p = 0.007) were independent predictors for AL-CA vs ATTR-CA differentiation, and combining these two parameters enhanced the diagnostic performance (bootstrapping AUC 0.847).

Conclusion: By providing pathophysiological insights into the distinctions between AL-CA and ATTR-CA, PV-loop parameters have the potential to serve as a complementary, contrast-free approach for differential diagnosis.

Key Points: Question PV-loop changes by CMR in CA patients with preserved LVEF remain unknown.

Findings Light-chain CA patients with preserved LVEF had higher NT-proBNP levels and lower PEI than transthyretin-related CA patients.

Critical relevance statement The CMR-derived PV-loop parameters revealed pathophysiological differences between the two subtypes of CA, suggesting potential differential diagnostic value.

Related

  1. Effect of Transthyretin Stabilizer in Transthyretin Cardiac Amyloidosis
    Toru Kubo, Yuri Ochi, Yuichi Baba +1
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationJ-STAGE
  2. Gender and Racial Distribution of Transthyretin Stabilizer Therapy in Patients With Transthyretin Cardiac Amyloidosis.
    Stephen J Foley, Shruti Hegde
    JACC. AdvancesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
  3. Taurine is a functional regulator of transthyretin; implication in transthyretin-induced hypothyroidism and amyloidosis
    Snigdha Krishna, Sheeza Khan, Laishram Rajendrakumar Singh
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  4. A Progressive 99mTc-MDP Uptake in Transthyretin Cardiac Amyloidosis
    Satoshi Kurisu, Hitoshi Fujiwara, Kosuke Asano
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationJ-STAGE
  5. The Progressive Cardiac Uptake of 99mTc-MDP as a Clue to Transthyretin Amyloidosis
    Kazufumi Nakamura
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationJ-STAGE
BibTeX
@article{liang2026myocardial,
  title = {{Myocardial work in light-chain and transthyretin-related amyloidosis with preserved ejection fraction: a cardiovascular magnetic resonance study}},
  author = {Shichu Liang and Jing Chen and Qiao Deng and Danni Li and Ke Wan and Keying Bi and Jiayu Sun and Qing Zhang and Yuchi Han and Yucheng Chen},
  journal = {Insights into imaging},
  year = {2026},
  month = oct,
  doi = {10.1186/s13244-026-02408-z},
  url = {https://europepmc.org/article/PMC/PMC13653009},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Myocardial work in light-chain and transthyretin-related amyloidosis with preserved ejection fraction: a cardiovascular magnetic resonance study
AU  - Shichu Liang
AU  - Jing Chen
AU  - Qiao Deng
AU  - Danni Li
AU  - Ke Wan
AU  - Keying Bi
AU  - Jiayu Sun
AU  - Qing Zhang
AU  - Yuchi Han
AU  - Yucheng Chen
PY  - 2026
DA  - 2026/10/09
JO  - Insights into imaging
DO  - 10.1186/s13244-026-02408-z
UR  - https://europepmc.org/article/PMC/PMC13653009
AB  - Objectives: To investigate pressure–volume loop (PV-loop) changes by cardiovascular magnetic resonance (CMR) imaging in cardiac amyloidosis (CA) patients with preserved left ventricular ejection fraction (LVEF), and to assess PV-loop parameters’ potential as subtype differential diagnostic markers.  Materials and methods: Between May 2017 and September 2023, 100 consecutive confirmed CA patients (14 transthyretin-related [ATTR-CA] and 86 light-chain [AL-CA]) and 40 age- and sex-matched healthy controls (HCs) were prospectively enrolled. PV-loop parameters were derived from CMR cine images and brachial blood pressure. Clinical and CMR parameters were compared between CA patients and HCs, as well as between CA subtypes. The correlations between PV-loop parameters and clinical and imaging parameters were assessed. Furthermore, the differential diagnostic performance of these PV-loop parameters was evaluated using the area under the receiver operating characteristic curve (ROC-AUC). Bootstrapping was performed 2000 times for internal validation.  Results: Compared to HCs, CA patients showed significantly lower stroke work index, potential energy index (PEI), and work efficiency (all p < 0.001). AL-CA patients had higher N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (2358.00 [IQR: 903.25, 5559.00] vs 810.00 [IQR: 269.00, 1136.01] pg/mL, p = 0.002) and lower PEI (0.13 [IQR: 0.07, 0.15] vs 0.15 [IQR: 0.13, 0.19] J/m², p = 0.025) than ATTR-CA patients. NT-proBNP (β = −1.94, OR = 0.14, 95% CI: 0.03–0.64, p = 0.016) and PEI (β = 0.20, OR = 1.23, 95% CI: 1.07–1.44, p = 0.007) were independent predictors for AL-CA vs ATTR-CA differentiation, and combining these two parameters enhanced the diagnostic performance (bootstrapping AUC 0.847).  Conclusion: By providing pathophysiological insights into the distinctions between AL-CA and ATTR-CA, PV-loop parameters have the potential to serve as a complementary, contrast-free approach for differential diagnosis.  Key Points: Question PV-loop changes by CMR in CA patients with preserved LVEF remain unknown.  Findings Light-chain CA patients with preserved LVEF had higher NT-proBNP levels and lower PEI than transthyretin-related CA patients.  Critical relevance statement The CMR-derived PV-loop parameters revealed pathophysiological differences between the two subtypes of CA, suggesting potential differential diagnostic value.
SN  - 1869-4101
ER  -